scholarly journals First Edition of Hahnemann's Organon: Celebrating its 200th Anniversary

Author(s):  
José Enrique Eizayaga

With this special issue, IJHDR celebrates the 200th anniversary of the first edition of Hahnemann’s Organon, published in 1810. By 1796, in a previous foundational article published in Hufeland’s prestigious Journal of Practical Medicine [1], after criticizing with fine reasoning the usual ways of studying the “curative properties of medicinal substances”, namely according to their chemical actions, their effects on animals, their external aspect or sensitive properties, their taxonomic classification, or the random use of multiple drugs by the so called empiricists, Hahnemann stated what can be regarded as one of the cornerstones of homeopathy: “The true physician, whose sole aim is to perfect his art, can avail himself of no other information respecting medicines, than – first, what is the pure action of each by itself on the human body? Second, what do observations of its action in this or that simple or complex disease teach us?” ... ... To conclude, despite uncertainties and difficulties homeopaths still have to struggle with, we can only feel grateful to Hahnemann’s countless efforts to introduce homeopathy and everything what it means in medicine history and development.

Biomedicines ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 64 ◽  
Author(s):  
Enrico Sangiovanni ◽  
Mario Dell’Agli

Inflammation is considered the first physiological response of the human body to infection or injury, playing a critical role in both innate and adaptive immunity [...]


2014 ◽  
Vol 4 (2) ◽  
Author(s):  
Sandy Campbell

This special issue of the Deakin Review of Children’s Literature is dedicated to health fiction.  The concept for the special issue grew out of an interest in using fiction as a tool in health literacy and healing.  Many of us have had the experience of escaping in to a book as a place of refuge when the real world seems too tough or being moved and inspired by a story about someone coping with illness, injury, or disability.  We wondered whether or not fictional works that offer children similar benefits are readily available? The answer is ‘Yes’, to a large extent.  But as we started to read our way through the books in local libraries, we realized that a number of the books may be of questionable benefit. Many had flaws, from obvious content errors to subtle issues that you might not recognize unless you read the book closely or someone brought them to your attention.  We wanted to take the opportunity to use this issue of Deakin to showcase some of the high quality fiction that we would recommend to libraries and parents. The authors of the reviews are librarians or other information professionals, with strengths in children's literature, health librarianship, or both.  Many have children.  Most are experienced reviewers.   Even though we had done some pre-screening, several of the reviewers started reviews and then discarded them when they found that upon close examination, they could not recommend the books. The accompanying article describes the larger study that we undertook to thoroughly review current children's health fiction. The end products of this research were: 1) a checklist for selection of children's health fiction; 2) a list of readily available works in the area; 3) this special theme issue of the Deakin, and; 4) a joint exhibit of the reviewed books, at the University of Alberta’s Education and Health Sciences libraries, to complement the publication of this issue. In addition to the outcomes mentioned above, it is our hope that an additional benefit of this project will be an increased community awareness of the value of children’s health fiction and the knowledge that sometimes a good story is good medicine. Sandy Campbell and Maria TanSandy is a Health Sciences Librarian at the University of Alberta, who has written hundreds of book reviews across many disciplines.  Sandy thinks that sharing books with children is one of the greatest gifts anyone can give. Maria C. Tan is a medical librarian at the Abdul Khaliq Library in Alberta Health Services’ Cross Cancer Institute and a former editorial team member of the Deakin Review. She firmly believes that children's literature is an essential component in the fountain of youth.


Author(s):  
Gennadi Glinsky

<p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p>Genes required for SARS-CoV-2 entry into human cells, <i>ACE2</i> and <i>FURIN</i>, were employed as baits to build genomics-guided molecular maps of up-stream regulatory elements, their expression and functions in human body, including pathophysiologically-relevant cell types. Repressors and activators of the <i>ACE2</i> and <i>FURIN</i> genes were identified based on the analyses of gene silencing and overexpression experiments as well as relevant transgenic mouse models. Panels of repressors (<i>VDR; GATA5; SFTPC; HIF1a</i>) and activators (<i>HMGA2; INSIG1</i>) were then employed to identify existing drugs manifesting gene expression signatures of the potential coronavirus infection mitigation agents. Using this strategy, Vitamin D and Quercetin have been identified as putative COVID-19 mitigation agents. Gene expression profiles of Vitamin D and Quercetin activities and their established safety records as over-the-counter medicinal substances suggest that they may represent viable candidates for further considerations of their potential utility as COVID-19 pandemic mitigation agents. Quercetin has been identified as one of top-scoring candidate therapeutics in the supercomputer SUMMIT drug-docking screen and Gene Set Enrichment Analyses (GSEA) of expression profiling experiments (EPEs), indicating that highly similar structurally Quercetin, Luteolin, and Eriodictyol could serve as scaffolds for development of efficient inhibitors of the SARS-CoV-2 infection. In agreement with this notion, Quercetin alters expression of 98 of 332 (30%) of human genes encoding protein targets of SARS-CoV-2, thus potentially interfering with functions of 23 of 27 (85%) of the SARS-CoV-2 viral proteins in human cells. GSEA and EPEs identify multiple drugs, smoking, and many disease conditions, including seasonal and pandemic H1N1, that appear to act as putative coronavirus infection-promoting agents. Discordant patterns of Testosterone versus Estradiol impacts on SARS-CoV-2 targets suggest a plausible molecular explanation of the apparently higher male mortality during coronavirus pandemic. Of major concern is the ACE2 and FURIN expression in many human cells and tissues, including immune cells, suggesting that SARS-CoV-2 coronavirus may infect a broad range of cellular targets in the human body. Infection of immune cells may cause immunosuppression, long-term persistence of the virus, and spread of the virus to secondary targets. Present analyses and numerous observational studies indicate that age-associated Vitamin D deficiency may contribute to high mortality of older adults and elderly. Immediate availability for targeted experimental and clinical interrogations of potential COVID-19 pandemic mitigation agents, namely Vitamin D and Quercetin, as well as of the highly selective (K<sub>i, </sub>600 pm) intrinsically-specific FURIN inhibitor (a1-antitrypsin Portland (a1-PDX), is considered an encouraging factor. Observations reported in this contribution are intended to facilitate follow-up targeted experimental studies and, if warranted, randomized clinical trials to identify and validate therapeutically-viable interventions to combat the COVID-19 pandemic. </p><p> <b></b><i></i><u></u><sub></sub><sup></sup><br></p>


Micromachines ◽  
2019 ◽  
Vol 10 (9) ◽  
pp. 615
Author(s):  
Qifa Zhou ◽  
Yi Zhang

Biomedical imaging is the key technique and process to create informative images of the human body or other organic structures for clinical purposes or medical science [...]


Author(s):  
TIMOTHY DARR ◽  
MARK KLEIN ◽  
DEBORAH L. McGUINNESS

In configuration design parts are selected and connected to meet customer specifications and engineering and physical constraints. Specifications include preferences (e.g., “prefer lower cost to higher performance, all things being equal”), bounds on various resources (e.g., “the computer should have four PCI slots”), and other information to customize a configuration. Constraints typically arise from exogenous concerns, such as the available parts, the way parts can interact, and the manufacturing plant.


2015 ◽  
Vol 18 (4) ◽  
Author(s):  
Basil D Roufogalis ◽  
Srinivas Nammi ◽  
Emanuel E Strehler

This Special Issue follows from a previous Issue entitled “Mechanism-Based Development of Natural Products for Human Health” arising from an inaugural conference on Natural Products Development held at Whistler Mountain, Canada from September 21-22, 2012. The timeliness of this issue reflects the continued growth in Natural Product research and the success of the First Issue, as judged from feedback we received and citations received. We were also encouraged by the interest in natural products research in recent years, as exemplified by the recent publication on Traditional Medicine in the prestigious journal Science (1, 2).


Sign in / Sign up

Export Citation Format

Share Document